Published in Exp Mol Pathol on April 01, 1986
Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Mol Cell Biol (2005) 1.24
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J (1997) 0.86
Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Eur J Epidemiol (1992) 0.81
Serum lipoproteins during bone marrow hyperplasia after phenylhydrazine administration in rats. Int J Exp Pathol (1990) 0.80
Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130). Br J Cancer (1995) 0.77
High-density lipoprotein contribute to G0-G1/S transition in Swiss NIH/3T3 fibroblasts. Sci Rep (2015) 0.75
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Diminished response to cytotoxic therapy in G-6-PD deficiency. Lancet (1980) 1.39
Neural correlates of cognitive control of reaching movements in the dorsal premotor cortex of rhesus monkeys. J Neurophysiol (2011) 1.29
Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study. J Hepatol (1999) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chem Biol Interact (1984) 1.26
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol (2001) 1.17
Microemulsions for topical delivery of 8-methoxsalen. J Control Release (2000) 1.16
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
A growth-constrained environment drives tumor progression invivo. Proc Natl Acad Sci U S A (2001) 1.11
Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest (1985) 1.09
Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J Lipid Res (1968) 1.08
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
Survey on the prevalence of leptospira infections in the Italian population. Eur J Epidemiol (1994) 1.01
Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol (1989) 0.98
Altered pattern of lipid metabolism in patients with lung cancer. Oncology (1992) 0.98
Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis (1995) 0.97
Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. Carcinogenesis (1990) 0.96
Cholesterol esters as growth regulators of lymphocytic leukaemia cells. Cell Prolif (2011) 0.91
Total and HDL cholesterol in human hematologic neoplasms. Int J Hematol (1991) 0.90
Liver cell proliferation induced by a single dose of lead nitrate. Am J Pathol (1983) 0.89
Sexually differentiated response to choline in choline deficiency and ethionine intoxication. Int J Exp Pathol (1995) 0.88
Variations of serum lipoproteins during cell proliferation induced by lead nitrate. Exp Mol Pathol (1989) 0.87
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J (1997) 0.86
Serum lipoprotein pattern as modified in G6PD-deficient children during haemolytic anaemia induced by fava bean ingestion. Int J Exp Pathol (1992) 0.86
Choline enhances acetylaminofluorene promotion of liver carcinogenesis in female but not in male rats. Carcinogenesis (1992) 0.86
Acinar cell carcinoma of rat pancreas: regulation of cholesterol esterification. Br J Cancer (1986) 0.86
Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets. Eur J Pharm Biopharm (2011) 0.85
Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability. Eur J Pharm Biopharm (2012) 0.84
Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization. Int J Pharm (2010) 0.84
G6PD activity and gene expression in leukemic cells from G6PD-deficient subjects. Cancer Lett (1999) 0.84
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis (1989) 0.84
1,25-dihydroxyvitamin D3, transforming growth factor beta1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes. J Invest Dermatol (1997) 0.84
Changes in serum and hepatic cholesterol in lead-induced liver hyperplasia. Toxicol Pathol (1984) 0.83
Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells. Cell Prolif (2002) 0.83
Sexual dimorphism in the regulation of cell turnover during liver hyperplasia. Chem Biol Interact (1995) 0.83
Cell proliferation in rat kidney induced by 1,2-dibromoethane. Toxicol Lett (1987) 0.83
Cholesterol and phospholipid composition of mitochondria and microsomes isolated from morris hepatoma 5123 and rat liver. FEBS Lett (1973) 0.83
Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies. Clin Sci (Lond) (1995) 0.83
Labelling of liver and plasma lecithins after injection of 1-2-14C-2-demethylaminoethanol and 14C-L-methionine-methyl to choline deficient rats. Lipids (1969) 0.83
Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol (1997) 0.82
Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis (1999) 0.81
The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis (1995) 0.81
Protein kinase C isozyme pattern in liver hyperplasia. Biochem Biophys Res Commun (1994) 0.81
MDR1 gene expression in normal and atherosclerotic human arteries(1). J Vasc Res (1999) 0.81
Measurement of Z boson production in Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.81
The resistance phenotype in the development and treatment of cancer. Lancet Oncol (2000) 0.81
MDR1, cholesterol certification and cell growth: a comparative study in normal and multidrug-resistant KB cell lines. Cell Mol Life Sci (2000) 0.81
Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery. Colloids Surf B Biointerfaces (2012) 0.81
Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Eur J Epidemiol (1992) 0.81
Chronic mitoinhibition during promotion of hepatocarcinogenesis. Dig Dis Sci (1991) 0.80
Liposome-incorporated santolina insularis essential oil: preparation, characterization and in vitro antiviral activity. J Liposome Res (2001) 0.80
Differential effects of choline administration on liver microsomes of female and male rats. Exp Mol Pathol (1978) 0.80
Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules. Carcinogenesis (1985) 0.80
Effects of the CCl 4 -cycloheximide interaction on protein synthesis and lipid metabolism in rat liver. Biochem Pharmacol (1971) 0.80
Hexose monophosphate shunt and cholesterogenesis in lead-induced kidney hyperplasia. Chem Biol Interact (1987) 0.80
Role of growth factor synthesis in the acquisition of insulin/insulin-like growth factor I independence in rat mammary carcinoma cells. Cancer Res (1990) 0.80
Lipid metabolism and molecular changes in normal and atherosclerotic vessels. Eur J Vasc Endovasc Surg (2001) 0.80
Failure of mitogen-induced cell proliferation to achieve initiation of rat liver carcinogenesis. Carcinogenesis (1987) 0.80
Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations. J Antimicrob Chemother (1997) 0.80
Mechanisms of the enhanced liver carcinogenesis by choline in female rats: delay in liver growth after partial hepatectomy and stimulation of 2-AAF mitoinhibition. Carcinogenesis (1992) 0.80
Early exposure to restraint stress enhances chemical carcinogenesis in rat liver. Cancer Lett (2000) 0.80
Hexose monophosphate shunt and cholesterol synthesis in the diabetic and fasting states. Exp Mol Pathol (1985) 0.80
Serum lipoproteins during bone marrow hyperplasia after phenylhydrazine administration in rats. Int J Exp Pathol (1990) 0.80
The changes in some hydrolytic enzymes in carbon tetrachloride-induced fatty livers. Biochem J (1964) 0.80
Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells. Cell Mol Life Sci (2001) 0.79
Epsilon PKC acts like a marker of progressive malignancy in rat liver, but fails to enhance tumorigenesis in rat hepatoma cells in culture. Biochem Biophys Res Commun (1996) 0.79
Hexose monophosphate shunt enzymes in lung tumors from normal and glucose-6-phosphate-dehydrogenase-deficient subjects. Oncology (1988) 0.79
N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats. Int J Pharm (2011) 0.79
Preservative systems containing essential oils in cosmetic products. Int J Cosmet Sci (2002) 0.79
Prevention by L-alpha-phosphatidylcholine of antifungal activity in vitro of liposome-encapsulated imidazoles determined by using time-killing curves. Int J Antimicrob Agents (2000) 0.79